Sleep disorders
Sleep apnea—most commonly obstructive sleep apnea (OSA)—is a disorder of recurrent upper‑airway collapse during sleep that leads to intermittent hypoxemia, fragmented sleep, and day‑to‑day symptoms (sleepiness, non‑restorative sleep, morning headache) along with long‑term cardiometabolic risks. Western medicine defines and stages OSA using polysomnography or home sleep apnea testing, quantifying the apnea‑hypopnea index (AHI): mild (5–14), moderate (15–29), and severe (≥30 events/hour), with diagnosis at AHI ≥15 or ≥5 with typical symptoms/comorbidities. Continuous positive airway pressure (CPAP) remains the gold standard therapy across severities because it pneumatically splints the airway, reliably normalizing respiratory events when used. Alternatives and adjuncts include mandibular advancement oral appliances, positional therapy, targeted surgeries (from uvulopalatopharyngoplasty to maxillomandibular advancement and hypoglossal nerve stimulation), weight reduction, and management of nasal obstruction. Evidence for cardiovascular event reduction with CPAP is nuanced: while it improves sleepiness and blood pressure, the large SAVE trial did not show fewer major cardiovascular events in largely non‑sleepy patients with suboptimal adherence, underscoring that benefits track with hours of nightly use. Weight management is a powerful disease modifier; intensive lifestyle programs and, more recently, anti‑obesity pharmacotherapy (for example, tirzepatide) can substantially reduce AHI, sometimes independent of CPAP.
Eastern and traditional perspectives frame OSA through different lenses but increasingly target similar mechanisms: collapsible airway, altered neuromuscular tone, and excess weight/kapha or phlegm‑damp accumulation. In Traditional Chinese Medicine (TCM), common patterns include phlegm‑dampness obstructing the oropharynx and spleen‑qi deficiency failing to transform fluids; treatment uses acupuncture (often with electroacupuncture) at local and systemic acu
Moderate Evidence
Sleep and Circadian Health
Sleep disorders encompass a broad set of conditions that disrupt sleep quality, timing, or duration, impairing daytime function. Common categories include insomnia disorder, obstructive sleep apnea (OSA), restless legs syndrome/periodic limb movement disorder (RLS/PLMD), narcolepsy and central hypersomnolence disorders, parasomnias, and circadian rhythm sleep-wake disorders. Western medicine relies on standardized diagnostic criteria (ICSD-3) and objective testing when indicated, and offers behavioral, circadian, device-based, and pharmacologic treatments. Among these, cognitive behavioral therapy for insomnia (CBT-I) is the gold-standard, first-line treatment for chronic insomnia. Pharmacologic options exist for select indications and short-term relief but carry important limitations. Circadian science underpins interventions such as timed light exposure and melatonin, which can be effective when precisely scheduled. Sleep studies (polysomnography, home sleep apnea testing, actigraphy, MSLT/MWT) help differentiate phenotypes and guide targeted care.
Eastern and traditional approaches frame sleep through distinct models. In Traditional Chinese Medicine (TCM), insomnia may reflect disharmony among organ systems (notably the Heart–Kidney axis) and disturbance of shen (mind/spirit). Acupuncture is commonly used and shows moderate, though heterogeneous, evidence for improving sleep quality and insomnia severity compared with waitlist or some active controls; evidence versus sham controls is mixed but trending favorable in newer reviews. TCM herbal strategies often include jujube seed (Suan Zao Ren) and formulae; broader Western herbal traditions use valerian and passionflower, and magnolia bark is sometimes included in stress/sleep formulations. The human evidence base for individual botanicals ranges from mixed (valerian) to emerging (passionflower, jujube seed, magnolia), with issues of standardization and study quality. In Ayurveda, healthy sleep (nidra) is a core
Well-Studied